Bordeaux

• Targeting ATR in soft-tissue sarcomas: a randomized phase II study Ended
  2023-509499-41-00 4 2022-02-03 Adult patients with locally advanced/unresectable and/or metastatic so
• A Study of TAS2940 in Participants With Locally Advanced or Metastatic Solid Tumor Cancer Ended
  2023-506922-35-00 1 2022-01-24 Locally Advanced or Metastatic Solid Tumors with EGFR and/or HER2 Aber
• Study to Compare Tivozanib in Combination with Nivolumab to Tivozanib Monotherapy in Subjects with Renal Cell Carcinoma Ended
  2024-514570-43-00 5 2022-01-24 Renal cell carcinoma
• Study comparing the standard administration of immunotherapy (IO) versus the same agent administered each three months in patients with loca … Ended
  2024-513707-14-00 5 2022-01-14 Only patients with oncologic locally advanced or metastatic tumour (lu
• A Phase 2, Open-Label, Multi-Center, Randomized Study of TAR-200 in Combination with Cetrelimab and Cetrelimab Alone in Participants with Mu … Ended
  2023-507189-17-00 4 2022-01-09 Muscle-Invasive Urothelial Carcinoma of the Bladder
• An Open-label Study to Investigate the Clinical Efficacy of Different Dosing Regimens of Efgartigimod IV in Patients With Generalized Myasth … Ended
  2024-510932-36-00 5 2021-12-21 Generalized Myasthenia Gravis (gMG)
• GEN1047 for Solid Tumors - First in Human (FIH) Trial Ended
  2024-510722-10-00 7 2021-12-13 Malignant Solid Tumors
• A randomized non-inferiority clinical trial of doxycycline vs BPG for early syphilis Ended
  2024-513532-23-00 5 2021-12-06 early syphilis
• An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects with Geographic Atrophy Secondary to … Ended
  2024-512945-18-00 5 2021-11-30 Geographic Atrophy Secondary to Age-Related Macular Degeneration
• Palivizumab-Controlled Evaluation of Safety, Efficacy, and Pharmacokinetics of MK-1654 in Infants and Children at Increased Risk for Severe … Ended
  2022-500752-39-00 5 2021-11-25 Prevention of Respiratory syncytial virus (RSV) infection in infants a
• VIRTUOSE: Efficiency of sildenafil on the absolute claudication distance of peripheral arterial disease patients with intermittent claudicat … Ended
  2024-516429-30-00 5 2021-11-24 Peripheral arterial disease
• A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity Ended
  2023-509196-16-00 6 2021-11-19 Upper limb spasticity (ULS) of any aetiology (in US and France) or pos
• A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients with Diffuse Cutaneous Systemic Sclerosis Ended
  2023-509782-20-00 4 2021-11-11 Diffuse Cutaneous Systemic Sclerosis
• Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications Ended
  2023-510511-19-00 7 2021-11-08 Advanced Solid Tumors
• A study to learn if bepranemab is safe and works in people with early stages of Alzheimer’s Disease Ended
  2023-506170-12-00 4 2021-10-18 Alzheimer’s Disease
• Asciminib treatment optimization in ≥ 3rd line CML-CP Ended
  2024-511381-36-00 5 2021-10-13 Chronic Myelogenous Leukemia in chronic phase (CML-CP)
• Proof-of-concept study for SAR445088 in chronic inflammatory demyelinating polyneuropathy (CIDP) Ended
  2024-512345-16-00 4 2021-10-13 Chronic inflammatory demyelinating polyradiculoneuropathy
• A study to assess the safety and efficacy of AZD7789 in participants with advanced or metastatic solid cancer Ended
  2022-502774-17-00 7 2021-10-04 Advanced or metastatic gastric and gastro-esophageal junction (GEJ) ad
• An Open-Label, Phase 2 Trial of Nanatinostat in Combination with Valganciclovir in Patients with Epstein-Barr Virus-Positive (EBV+) Relapsed … Ended
  2024-512717-41-00 4 2021-10-01 Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas
• A Randomized, Open-Label Trial to Compare Tisotumab Vedotin to Investigator's Choice Chemotherapy in Patients with Cervical Cancer Ended
  2023-503813-31-01 5 2021-09-17 Second- or Third-Line Recurrent or Metastatic Cervical Cancer
• First-in-Human Study of RLY-4008 in Patients With ICC and Other Advanced Solid Tumors Ended
  2024-512622-29-00 7 2021-09-10 Cholangiocarcinoma (CCA) and Other Advanced Solid Tumors
• A study of PRS-344/S095012 (PD-L1x4-1BB bispecific antibody) in patients with solid tumors Ended
  2023-510046-25-00 7 2021-09-02 Soild Tumors
• A Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients with Metastatic Colorectal Cancer Ended
  2024-511158-36-00 9 2021-08-05 Metastatic colorectal cancer
• Integrative analysis of the tumor microenvironment and optimization of the immunotherapy duration in non-small cell lung cancer patients. Ended
  2023-509490-23-00 4 2021-08-03 Patients with locally advanced or metastasic Non-Small Cell Lung Carci

Showing 985–1,008 of 1,096 trials